IS6223A - Fjölbrigða salt - Google Patents

Fjölbrigða salt

Info

Publication number: IS6223A
Authority: IS; Iceland
Prior art keywords: polymeric salt; polymeric; salt
Prior art date: 1999-09-28

Application number

IS6223A

Other languages

English (en)

Other versions

IS2162B (is

Inventor

Bentley Arthur

Arnold Howard-Field Simon

James Ogilvie Ronald

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-28

Filing date

2002-01-08

Publication date

2002-01-08

2002-01-08 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2002-01-08 Publication of IS6223A publication Critical patent/IS6223A/is

2006-11-15 Publication of IS2162B publication Critical patent/IS2162B/is

Links

150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Otolaryngology (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Addiction (AREA)
Obesity (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Nutrition Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IS6223A 1999-09-28 2002-01-08 Fjölbrigðasalt af lyfi gegn mígreni IS2162B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9922963.5A GB9922963D0 (en)	1999-09-28	1999-09-28	Polymorphic salt
PCT/IB2000/001305 WO2001023377A2 (en)	1999-09-28	2000-09-14	Polymorphic salt

Publications (2)

Publication Number	Publication Date
IS6223A true IS6223A (is)	2002-01-08
IS2162B IS2162B (is)	2006-11-15

Family

ID=10861767

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6223A IS2162B (is)	1999-09-28	2002-01-08	Fjölbrigðasalt af lyfi gegn mígreni

Country Status (50)

Country	Link
US (1)	US6369094B1 (is)
EP (1)	EP1233960B1 (is)
JP (1)	JP3795395B2 (is)
KR (1)	KR100479897B1 (is)
CN (1)	CN1155594C (is)
AP (1)	AP2004A (is)
AR (1)	AR025779A1 (is)
AT (1)	ATE246185T1 (is)
AU (1)	AU779580B2 (is)
BG (1)	BG65161B1 (is)
BR (1)	BR0014272A (is)
CA (1)	CA2379572C (is)
CO (1)	CO5180567A1 (is)
CR (1)	CR6561A (is)
CU (1)	CU23200A3 (is)
CZ (1)	CZ2002971A3 (is)
DE (1)	DE60004262T2 (is)
DK (1)	DK1233960T3 (is)
DZ (1)	DZ3254A1 (is)
EA (1)	EA004510B1 (is)
EE (1)	EE200200171A (is)
EG (1)	EG24143A (is)
ES (1)	ES2200911T3 (is)
GB (1)	GB9922963D0 (is)
GE (1)	GEP20043365B (is)
GT (1)	GT200000159A (is)
HK (1)	HK1048628B (is)
HR (1)	HRP20020270B1 (is)
HU (1)	HUP0202821A3 (is)
IL (1)	IL147154A (is)
IS (1)	IS2162B (is)
MA (1)	MA26821A1 (is)
MX (1)	MXPA02003311A (is)
MY (1)	MY121170A (is)
NO (1)	NO321936B1 (is)
NZ (1)	NZ516093A (is)
OA (1)	OA12024A (is)
PA (1)	PA8498901A1 (is)
PE (1)	PE20010662A1 (is)
PL (1)	PL354960A1 (is)
PT (1)	PT1233960E (is)
SI (1)	SI1233960T1 (is)
SK (1)	SK3982002A3 (is)
TN (1)	TNSN00187A1 (is)
TR (1)	TR200200804T2 (is)
TW (1)	TWI265926B (is)
UA (1)	UA72272C2 (is)
WO (1)	WO2001023377A2 (is)
YU (1)	YU2602A (is)
ZA (1)	ZA200202406B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060025387A1 (en) *	1998-12-23	2006-02-02	Cytoscan Sciences Llc	Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
US8722668B2 (en) *	1998-12-23	2014-05-13	Daryl W. Hochman	Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) *	1998-12-23	2007-05-08	Neurotherapeutics Pharma Llc	Method of treating migraine headache without aura
US8008283B2 (en) *	1998-12-23	2011-08-30	Neurotherapeutics Pharma, Inc.	Methods and compositions for the treatment of neuropsychiatric disorders
GB0018968D0 (en) *	2000-08-02	2000-09-20	Pfizer Ltd	Particulate composition
US7132549B2 (en)	2003-05-30	2006-11-07	Pfizer Inc.	Process
GB0312478D0 (en) *	2003-05-30	2003-07-09	Pfizer Ltd	Improved process
ES2727577T5 (en) *	2004-12-03	2025-04-02	Merck Sharp & Dohme Llc	Pharmaceutical composition containing an anti-nucleating agent
US20070149526A1 (en) *	2005-10-17	2007-06-28	Neurotherapeutics Pharma, L.L.C.	Diuretic and diuretic-like compound analogs
KR100814109B1 (ko) *	2006-01-09	2008-03-14	한국생명공학연구원	로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물
TWI394753B (zh)	2006-03-17	2013-05-01	Otsuka Pharma Co Ltd	新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體
WO2010116386A2 (en) *	2009-04-08	2010-10-14	Biophore India Pharmaceuticals Pvt. Ltd.	Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
EP3970702A1 (en)	2009-10-26	2022-03-23	Merck Sharp & Dohme Corp.	Solid pharmaceutical compositions containing an integrase inhibitor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5559246A (en)	1990-10-15	1996-09-24	Pfizer Inc.	Indole derivatives
PL168919B1 (pl) *	1990-10-15	1996-05-31	Pfizer	Sposób wytwarzania nowych pochodnych indolu PL PL PL PL
US5559129A (en)	1990-10-15	1996-09-24	Pfizer Inc	Indole derivatives
US5545644A (en)	1990-10-15	1996-08-13	Pfizer Inc.	Indole derivatives
US5578612A (en)	1990-10-15	1996-11-26	Pfizer Inc.	Indole derivatives
US5607951A (en)	1990-10-15	1997-03-04	Pfizer Inc	Indole derivatives
GB9417310D0 (en) *	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents
US5998462A (en) *	1996-12-16	1999-12-07	Allelix Biopharmaceuticals Inc.	5-alkyl indole compounds
JP3350061B2 (ja)	1997-07-03	2002-11-25	ファイザー・インク	エレトリプタンヘミスルフェートおよびカフェインを含有する医薬組成物

1999
- 1999-09-28 GB GBGB9922963.5A patent/GB9922963D0/en not_active Ceased
2000
- 2000-07-25 TW TW089114850A patent/TWI265926B/zh not_active IP Right Cessation
- 2000-07-28 PA PA20008498901A patent/PA8498901A1/es unknown
- 2000-08-10 CO CO00059853A patent/CO5180567A1/es not_active Application Discontinuation
- 2000-09-14 BR BR0014272-7A patent/BR0014272A/pt not_active Application Discontinuation
- 2000-09-14 EE EEP200200171A patent/EE200200171A/xx unknown
- 2000-09-14 AU AU67213/00A patent/AU779580B2/en not_active Ceased
- 2000-09-14 DK DK00954864T patent/DK1233960T3/da active
- 2000-09-14 ES ES00954864T patent/ES2200911T3/es not_active Expired - Lifetime
- 2000-09-14 UA UA2002032432A patent/UA72272C2/uk unknown
- 2000-09-14 AP APAP/P/2002/002457A patent/AP2004A/en active
- 2000-09-14 HR HR20020270A patent/HRP20020270B1/xx not_active IP Right Cessation
- 2000-09-14 NZ NZ516093A patent/NZ516093A/xx unknown
- 2000-09-14 YU YU2602A patent/YU2602A/sh unknown
- 2000-09-14 SK SK398-2002A patent/SK3982002A3/sk unknown
- 2000-09-14 GE GE4699A patent/GEP20043365B/en unknown
- 2000-09-14 PL PL00354960A patent/PL354960A1/xx not_active IP Right Cessation
- 2000-09-14 IL IL14715400A patent/IL147154A/xx not_active IP Right Cessation
- 2000-09-14 KR KR10-2002-7003963A patent/KR100479897B1/ko not_active Expired - Fee Related
- 2000-09-14 HU HU0202821A patent/HUP0202821A3/hu unknown
- 2000-09-14 JP JP2001526529A patent/JP3795395B2/ja not_active Expired - Fee Related
- 2000-09-14 MX MXPA02003311A patent/MXPA02003311A/es active IP Right Grant
- 2000-09-14 CA CA002379572A patent/CA2379572C/en not_active Expired - Fee Related
- 2000-09-14 DE DE60004262T patent/DE60004262T2/de not_active Expired - Lifetime
- 2000-09-14 OA OA1200200077A patent/OA12024A/en unknown
- 2000-09-14 AT AT00954864T patent/ATE246185T1/de not_active IP Right Cessation
- 2000-09-14 CZ CZ2002971A patent/CZ2002971A3/cs unknown
- 2000-09-14 SI SI200030165T patent/SI1233960T1/xx unknown
- 2000-09-14 CN CNB00810798XA patent/CN1155594C/zh not_active Expired - Fee Related
- 2000-09-14 TR TR2002/00804T patent/TR200200804T2/xx unknown
- 2000-09-14 EA EA200200302A patent/EA004510B1/ru not_active IP Right Cessation
- 2000-09-14 PT PT00954864T patent/PT1233960E/pt unknown
- 2000-09-14 EP EP00954864A patent/EP1233960B1/en not_active Expired - Lifetime
- 2000-09-14 WO PCT/IB2000/001305 patent/WO2001023377A2/en not_active Ceased
- 2000-09-14 DZ DZ003254A patent/DZ3254A1/fr active
- 2000-09-14 HK HK03100144.2A patent/HK1048628B/zh not_active IP Right Cessation
- 2000-09-19 US US09/664,946 patent/US6369094B1/en not_active Expired - Fee Related
- 2000-09-25 EG EG20001216A patent/EG24143A/xx active
- 2000-09-26 PE PE2000001010A patent/PE20010662A1/es not_active Application Discontinuation
- 2000-09-26 AR ARP000105032A patent/AR025779A1/es active IP Right Grant
- 2000-09-26 GT GT200000159A patent/GT200000159A/es unknown
- 2000-09-26 MY MYPI20004476A patent/MY121170A/en unknown
- 2000-09-27 TN TNTNSN00187A patent/TNSN00187A1/fr unknown
2001
- 2001-12-10 CU CU20010293A patent/CU23200A3/es not_active IP Right Cessation
- 2001-12-19 BG BG106240A patent/BG65161B1/bg unknown
2002
- 2002-01-08 IS IS6223A patent/IS2162B/is unknown
- 2002-01-24 CR CR6561A patent/CR6561A/es not_active Application Discontinuation
- 2002-03-15 MA MA26556A patent/MA26821A1/fr unknown
- 2002-03-26 ZA ZA200202406A patent/ZA200202406B/en unknown
- 2002-03-26 NO NO20021525A patent/NO321936B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CU23200A3 (es)	2007-04-06
IL147154A (en)	2005-11-20
CN1155594C (zh)	2004-06-30
JP3795395B2 (ja)	2006-07-12
DK1233960T3 (da)	2003-10-27
AP2004A (en)	2009-06-10
DZ3254A1 (fr)	2001-04-05
CA2379572A1 (en)	2001-04-05
IS2162B (is)	2006-11-15
HK1048628A1 (en)	2003-04-11
BG106240A (en)	2002-07-31
CR6561A (es)	2005-04-04
EP1233960B1 (en)	2003-07-30
PA8498901A1 (es)	2004-02-07
HUP0202821A3 (en)	2003-12-29
NO20021525D0 (no)	2002-03-26
GB9922963D0 (en)	1999-12-01
TWI265926B (en)	2006-11-11
HRP20020270B1 (en)	2004-04-30
SI1233960T1 (en)	2003-12-31
GT200000159A (es)	2002-03-20
BG65161B1 (bg)	2007-04-30
EP1233960A2 (en)	2002-08-28
WO2001023377A3 (en)	2002-03-07
TR200200804T2 (tr)	2002-07-22
KR20020032627A (ko)	2002-05-03
DE60004262D1 (de)	2003-09-04
CN1364166A (zh)	2002-08-14
NO321936B1 (no)	2006-07-24
TNSN00187A1 (fr)	2005-11-10
YU2602A (sh)	2004-11-25
MA26821A1 (fr)	2004-12-20
NZ516093A (en)	2005-01-28
EA200200302A1 (ru)	2002-10-31
EE200200171A (et)	2003-06-16
CO5180567A1 (es)	2002-07-30
ATE246185T1 (de)	2003-08-15
HUP0202821A2 (hu)	2003-01-28
OA12024A (en)	2006-04-19
MXPA02003311A (es)	2002-10-04
PL354960A1 (en)	2004-03-22
NO20021525L (no)	2002-03-26
PT1233960E (pt)	2003-11-28
CZ2002971A3 (cs)	2003-04-16
KR100479897B1 (ko)	2005-03-31
ZA200202406B (en)	2003-05-28
EA004510B1 (ru)	2004-04-29
IL147154A0 (en)	2002-08-14
AR025779A1 (es)	2002-12-11
GEP20043365B (en)	2004-05-10
DE60004262T2 (de)	2004-01-22
WO2001023377A2 (en)	2001-04-05
AP2002002457A0 (en)	2002-06-30
SK3982002A3 (en)	2003-05-02
BR0014272A (pt)	2002-05-21
AU779580B2 (en)	2005-01-27
UA72272C2 (uk)	2005-02-15
ES2200911T3 (es)	2004-03-16
EG24143A (en)	2008-08-06
PE20010662A1 (es)	2001-06-23
HK1048628B (zh)	2004-10-21
HRP20020270A2 (en)	2003-06-30
AU6721300A (en)	2001-04-30
US6369094B1 (en)	2002-04-09
WO2001023377A9 (en)	2002-03-28
MY121170A (en)	2005-12-30
JP2003510318A (ja)	2003-03-18
CA2379572C (en)	2006-11-14

Publication	Publication Date	Title
DE60036160D1 (de)	2007-10-11	Elektroentionisierungsvorrichtung
DE60018571T8 (de)	2006-04-27	Hernienprothese
DE50010505D1 (de)	2005-07-14	Gurtaufrollersystem
DE19983871T1 (de)	2002-01-31	Fönvorrichtung
DE10084676T1 (de)	2003-04-30	Einmallanzettvorrichtung
DE60010560D1 (de)	2004-06-17	Ausgleichungsgewicht
PT1218009E (pt)	2005-05-31	Grandulos de quetiapina
ATE297895T1 (de)	2005-07-15	4-pyridinyl-n-acyl-l-phenylalanine
DE60023890D1 (de)	2005-12-15	Celluligninbrennstoff
DE50009570D1 (de)	2005-03-31	Wechselcorrugator
PT1218096E (pt)	2004-08-31	Microcapsulas de libertacao variavel
DE60001649D1 (de)	2003-04-17	Ziprasidonsuspension
DE60012888D1 (de)	2004-09-16	Mevinolinderivate
PT1163256E (pt)	2004-07-30	Hemi-hidrato de 16-alfa-bromoepiandrosterona
DE60013054D1 (de)	2004-09-23	Reissverschlusszuglasche
IS6223A (is)	2002-01-08	Fjölbrigða salt
DE60022878D1 (de)	2006-02-09	Konzentrizitätsring
DE69935066D1 (de)	2007-03-22	Befehlsvorausholeinheit
DE60043569D1 (de)	2010-02-04	Elektrodenherstellverfahren
DE60011195D1 (de)	2004-07-08	Narkosemittelverdunster
DE60025623D1 (de)	2006-04-06	Bohrmeisselverbinder
PT1235566E (pt)	2005-08-31	Formulacao injectavel de valnemulina
DE60000107D1 (de)	2002-05-08	Formschliessvorrichtung
DE69935205D1 (de)	2007-04-05	Unterbrechungssteurerungssystem
FI4283U1 (fi)	1999-12-31	Höyrylaatikko